Previous close | 204.92 |
Open | 204.88 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 1000 |
Day's range | 203.54 - 206.36 |
52-week range | 159.21 - 255.93 |
Volume | |
Avg. volume | 538,470 |
Market cap | 20.574B |
Beta (5Y monthly) | 0.81 |
PE ratio (TTM) | 53.95 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 1.88 (0.92%) |
Ex-dividend date | 21 Nov 2022 |
1y target est | N/A |
DUBLIN, IRELAND, Jan. 25, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2023 third quarter financial results at 10:00 a.m. ET on February 9, 2023. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing third quarter
As reported revenue was flat; 7% constant currency organic revenue growthAs reported loss per share of ($3.15); adjusted EPS of $1.99As reported loss includes an impairment charge of $490.6 million related to the Dental segment DUBLIN, IRELAND, Nov. 09, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2023 second quarter ended September 30, 2022. Revenue as reported for the quarter was flat at $1.2 billion compared with
DUBLIN, IRELAND, Nov. 02, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that the Company will distribute a quarterly interim dividend of $0.47 per share. The dividend is payable December 16, 2022 to shareholders of record at the close of business on November 22, 2022. STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD